---

PUBLICATIONS

---

Partial list of publications from the last 5 years.

Referred Journals and Invited Reviews

• H. Uludag, J. Yang. Targeting systemically administered proteins to bone by bisphosphonate conjugation. Biotech. Prog. (2002) 18:604-611.
  
  

• H. Uludag. Bisphosphonates as a foundation for drug delivery to bone. Curr. Pharm. Design (2002) 8:1929-1944.
  
  

• T.J. Gao, N.A. Kousinioris, J.M. Wozney, H. Uludag. Synthetic thermoreversible polymers are compatible with osteoinductive activity of rhBMP-2. Tissue Eng. (2002) 8:429-440.
  
  

• S. Gittens, H. Uludag. Growth Factor delivery for bone tissue engineering. J. Drug Targeting (2001) 9:407-429.
  
  

• H. Uludag, T. Gao, T. Porter, W. Friess, J.M. Wozney. Delivery systems for BMPs: factors contributing to protein retention at an application site. J. Bone Joint Surg. (2001) 83A: 128-135.
  
  

• H. Uludag, B. Norrie, N. Kousinioris, T. Gao. Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins. Biotech. Bioeng. (2001) 73: 510-521.
  
  

• H. Uludag, P. de Vos, P. Tresco. Technology of mammalian cell encapsulation. Adv. Drug Del. Rev. (2000) 42: 29-64.
  
  

• H. Uludag, D. D'Augusta, J. Golden, J. Li, G. Timony, R. Riedel, J.M. Wozney. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteinduction in the rat ectopic model. J. Biomed. Mat. Res. (2000) 50: 227-238.
  
  

• H. Uludag, N. Kousinioris, T. Gao, D. Kantoci. Targeting proteins to bone by conjugation to bisphosphonates: in vitro assessment of mineral affinity. Biotech. Prog. (2000) 16: 258-267.
  
  

• H. Uludag, M. Wong, J. Man. Reactivity of temperature-sensitive, protein-conjugating polymers prepared by a photopolymerization process. J. Appl. Polym. Sci (2000) 75: 583-592.
  
  

• S.R. Winn, G. Randolph, H. Uludag, S.C. Wong, J.O. Hollinger. Establishing an immortilized human osteoprecurser cell line: OPC1. J. Bone. Min. Res. (1999) 14: 1721-1733.
  
  

• W. Friess, H. Uludag, S. Foskett, R. Biron, C. Sargeant. Interactions in rhBMP-2/Absorbable collagen sponge systems for bone regeneration. Int. J. Pharmaceu. (1999) 185: 51-60.
  
  

• H. Uludag, J. Golden, R. Palmer, J.M. Wozney. Biotinated Bone Morphogenetic Protein-2: in vivo and in vitro activity. Biotech. Bioeng. (1999) 65: 668-672.
  
  

• S.R. Winn, H. Uludag, J.O. Hollinger. Carrier systems for Bone Morphogenetic Proteins. Clin. Orthop. (1999), 367S: 95-106.
  
  

• H. Uludag, D. D'Augusta, R. Palmer, G. Timony, J.M. Wozney. Pharmacokinetic characterization of rhBMP-2 implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mat. Res. (1999) 46: 193-202.
  
  

• H. Uludag. Osteoinductive alternatives to bone grafts. Cur. Opin. in Orthop. (1998) 9: 31-37.
  
  

• S. Winn, H. Uludag, J. Hollinger. Delivery of Bone Morphogenetic Proteins. Adv. Drug Del. Rev. (1998) 31 : 303-318.
  
  

Book Chapters

• T.J. Gao, H. Uludag. Injectable formulation of biomaterials as a delivery systerm for BMP. In Advances in Skeletal Reconstruction Using Bone Morphogenetic Proteins. T.S. Lindholm (Ed), World Scientific Publishing Co., River Edge, NJ (2002) 125-141.
  
  

• H. Uludag, X.D. Fan. Synthesis and characterization of thermoreversible, protein-conjugating copolymers based on N-isopropylacrylamide. In Drug Delivery in the 21st Century, K. Park and R. Mrsny (Eds), ACS Symposium Series, Washington, DC (2000), Vol 752, 253-262.
  
  

• H. Uludag, W. Friess, D. Williams, G. Timony, D. D'Augusta, C. Sargent, B. Biron, J. Wozney. rhBMP/collagen sponges as osteoinductive devices: effects of sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. In NY Acad. Sci. (1999) Volume 875: 369-378.